Shang-yin K. Wu
No. 138 Sheng Li Rd
Tainan, TNQ, Taiwan
Tainan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Lysine as a multifunctional excipient for protein-based biopharmaceutical formulations.
Journal: International journal of pharmaceutics
Published: May 18, 2026
Chemical degradation of histidine residues and histidine as an excipient in protein-based biopharmaceuticals.
Journal: International journal of pharmaceutics
Published: March 09, 2026
Dynamic 3D imaging system detects vasculogenic mimicry and screens inhibitors in EGFR-mutant lung cancer.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 04, 2026
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 10, 2026
Single-cell analysis reveals crosstalk between TREM1-positive myeloid cells and cancer-associated fibroblasts in colorectal cancer progression.
Journal: Journal of gastroenterology
Published: December 30, 2025
Pretreatment feeding‑stoma placement in advanced esophageal cancer: defining optimal patient selection criteria.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: December 28, 2025
Clinical and immunological implications of lymphocyte-activation gene 3 expression in metastatic colorectal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: November 07, 2025
A label-free multi-parameter screening method for predicting the stability of mRNA-LNP formulations.
A label-free multi-parameter screening method for predicting the stability of mRNA-LNP formulations.
Journal: International journal of pharmaceutics
Published: October 15, 2025
Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.
Journal: Journal of biomedical science
Published: February 19, 2025
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors.
Journal: The oncologist
Published: September 05, 2024
Last Updated: 09/26/2026